Dr. Mikhail R. Malek, MD

Dr. Malek practices at Poway Surgery Center in Poway, California.

Dr. Malek's NPI, 1467455212, was assigned on May 24, 2005. Dr. Malek graduated from Cairo University School of Medicine in 1978. Dr. Malek holds California license A50952.

Dr. Malek's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Malek's primary practice is Poway Surgery Center in Poway, California. Dr. Malek is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Malek to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malek practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Malek's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Malek is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Malek's licenses on file in 2 states: California and Illinois.

Dmand AI lists angioplasty, cardiac catheterization, pacemaker or defibrillator implantation and pacemaker replacement among the conditions Dr. Malek treats.

CMS data shows 1,445 Medicare services from Dr. Malek across 13 procedure codes in 2024, for 461 Medicare patients. Medicare paid $105,287 for them.

CMS counts 461 Medicare patients who saw Dr. Malek in 2024. The largest group is 75 to 84, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Malek's median patient age at 76, with 42% women.

In 2024, Dr. Malek wrote 3,931 Medicare Part D claims for 415 patients. 87% of them were for generic drugs. CMS names the drug for 3,714 of them, across 43 drugs with 11 or more claims each, at $583,541 in total drug cost. In 2023, CMS named 3,538 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 9 out of 100 for Dr. Malek for performance year 2024, reported individually. Dr. Malek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 173 general payments to Dr. Malek from 30 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 54% of the total. Medtronic Vascular, Inc. paid the most, $12,842.

Dmand AI lists 3 awards for Dr. Malek, most recently CMS Stage 1 EHR in 2013.

Dr. Malek graduated from Cairo University School of Medicine in 1978. Dr. Malek is a member of ACC.

Dr. Malek is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.